Taysha Gene Therapies
TSHA
TSHA
86 hedge funds and large institutions have $231M invested in Taysha Gene Therapies in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.2% more ownership
Funds ownership: 69.52% → 69.72% (+0.2%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
44% less capital invested
Capital invested by funds: $411M → $231M (-$180M)
Holders
86
Holding in Top 10
2
Calls
$259K
Puts
$61K
Top Buyers
| 1 | +$6.74M | |
| 2 | +$4.58M | |
| 3 | +$4.39M | |
| 4 |
EP
Eversept Partners
New York
|
+$4.14M |
| 5 |
BlackRock
New York
|
+$3.89M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$10.4M | |
| 3 | -$8.78M | |
| 4 |
VA
VR Adviser
New York
|
-$8.04M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.16M |